CSTL

Castle Biosciences Stock Analysis

AI Rating

Fair
  • Quality4/10
  • Growth↓ 0/10
  • Momentum↑ 6/10
Castle Biosciences sales and earnings growth
CSTL Growth
Low
  • Revenue Y/Y↑ 10.15%
  • EPS Y/Y↓ -286.36%
  • FCF Y/Y↓ -26.41%
Castle Biosciences gross and profit margin trends
CSTL Profitability
Neutral
  • Gross margin ↑ 79.90%
  • EPS margin↓ -3.60%
  • ROIC↓ -5.70%
Castle Biosciences net debt vs free cash flow
CSTL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -121.8

Castle Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Diagnostics & Research stocks ↗